group.bmj.com on June 22, 2017 -Published by http://heart.bmj.com/ Downloaded from followed by an infusion of heparin at the rate of 1000 units per hour for 24 hours to maintain the clotting time at one and a half times his basal clotting time (measured at the start of treatment), and aspirin (150 mg per day). Phonocardiographic recordings were obtained every hour with the microphone placed at the same position.
Two hours after treatment started the patient reported that he could hear faint valve sounds. Physical examination showed a decrease in the aortic ejection murmur and the closing sounds of the prosthetic valve were clearly audible. The phonocardiographic recording confirmed the findings (fig IB) . Six hours later the patient could clearly hear the prosthetic valve sounds "normally". At auscultation sharp opening and closing prosthetic valve sounds and a soft aortic ejection murmur were heard. The phonocardiogram confirmed these findings (fig 1 C) In this patient the complete absence of prosthetic valve sounds and development of exertional dyspnoea along with his history of not taking anticoagulant therapy pointed strongly to a diagnosis of prosthetic valve thrombosis. Serial phonocardiograms provided an objective index of thrombolysis (figure). Though the patient's symptoms were mild, there was every likelihood of lifethreatening valve obstruction or systemic embolisation,16 so urgent intervention was warranted. When thrombolytic treatment is not effective, surgical intervention is indicated. In our patient streptokinase therapy was successful and the patient experienced complete relief of dyspnoea and the return of audible valve sounds. Potential complications of thrombolytic therapy include allergic reactions to streptokinase, haemorrhages owing to the systemic lytic state or systemic thromboembolism caused by loss of adhesion between a partially lysed thrombus and the prosthesis.8 Our patient experienced no complications of the thrombolytic therapy.
As thrombolytic agents become more potent, safe, and thrombus-specific, the need for surgical intervention for thrombotic complications of prosthetic valves should be reduced. 
